You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoadjuvant

Showing 1 - 25 of 5,298
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer Trial (Neoadjuvant Chemoradiotherapy, Total Neoadjuvant Therapy)

Not yet recruiting
  • Rectal Cancer
  • Neoadjuvant Chemoradiotherapy
  • Total Neoadjuvant Therapy
  • (no location specified)
Oct 24, 2023

Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

Recruiting
  • Non-Small Cell Lung Cancer
  • Neoadjuvant immunochemotherapy
  • Neoadjuvant chemotherapy
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Aug 1, 2023

Candidates for Neoadjuvant Treatment in Resectable Pancreatic

Completed
  • Pancreatic Cancer
  • Neoadjuvant
  • Neoadjuvant treatment
  • (no location specified)
Nov 9, 2023

Breast Cancer, Implant Breast Reconstruction, Neoadjuvant Radiotherapy Trial in Wuhan (Neoadjuvant radiotherapy)

Recruiting
  • Breast Cancer
  • +2 more
  • Neoadjuvant radiotherapy
  • Wuhan, Hubei, China
    Xinhong Wu
Aug 8, 2023

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of

Not yet recruiting
  • Organoids
  • +2 more
  • Biopsy
  • (no location specified)
Nov 24, 2023

Colon Cancer Trial (Neoadjuvant chemo)

Not yet recruiting
  • Colon Cancer
  • Neoadjuvant chemotherapy
  • (no location specified)
Oct 25, 2023

Neoadjuvant Immunochemotherapy for Lung Cancer

Completed
  • Lung Cancer
  • Neoadjuvant immunochemotherapy
  • Shanghai, Shanghai, China
    Zhencong Chen
Sep 1, 2023

Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)

Not yet recruiting
  • Biliary Tract Neoplasms
  • Total Neoadjuvant Treatment
  • (no location specified)
Sep 7, 2023

Micrometastases in Axillary Lymph Nodes in Breast Cancer,

Completed
  • Micrometastases
  • Neoadjuvant Chemotherapy
  • Sentinel lymph node biopsy, axillary lymph node dissection
  • (no location specified)
Nov 20, 2023

Breast Cancer Female Trial (Pyrotinib and Trastuzumab)

Not yet recruiting
  • Breast Cancer Female
  • Pyrotinib and Trastuzumab
  • (no location specified)
Sep 11, 2023

Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)

Recruiting
  • Colon Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Aug 26, 2023

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023

Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 15, 2023

Head and Neck Squamous-cell Carcinoma

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
    • (no location specified)
    Nov 5, 2023

    Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant

    Not yet recruiting
    • Multiple Cancer
    • Colorectal Cancer
    • MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
    • All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
    • (no location specified)
    Aug 20, 2023

    Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)

    Recruiting
    • Colonic Neoplasms
    • +2 more
    • Nanning, Guangxi, China
      The First Affiliated Hospital of Guangxi Medical University
    Nov 9, 2023

    Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

    Not yet recruiting
    • Locally Advanced Rectal Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Aug 5, 2023

    Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)

    Recruiting
    • Thymic Carcinoma
    • Envolizumab combined with radiotherapy
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Sep 3, 2023

    Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)

    Recruiting
    • Esophageal Carcinoma
    • Neoadjuvant Immunotherapy
    • PD-1 blockade
    • +2 more
    • Beijing, Beijing, China
      Qin li
    Mar 8, 2023

    NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Yangzhou, Jiangsu, China
      People's hospital of northern jiangsu
    Sep 26, 2023

    Surgery After Neoadjuvant Chemotherapy in Locally Advanced

    Completed
    • Postoperative Complications
    • surgery after neoadjuvant chemotherapy
    • Seoul, Korea, Republic of
      Asan medical center
    Jun 1, 2023

    Rectal Cancer Trial in Osaka (radiation, drug, procedure)

    Recruiting
    • Rectal Cancer
    • Radiation
    • +2 more
    • Osaka, Japan
    • +1 more
    Jul 1, 2023

    Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy Trial (neoadjuvant anti-PD-1 (Keytruda) plus chemo)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Neoadjuvant Chemoimmunotherapy
    • neoadjuvant anti-PD-1 (Keytruda) plus chemotherapy
    • (no location specified)
    Feb 14, 2023

    Esophageal Cancer, Active Surveillance, Neoadjuvant Chemoradiotherapy Trial in Rotterdam (Active surveillance)

    Active, not recruiting
    • Esophageal Cancer
    • +3 more
    • Active surveillance
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus MC, University Medical Center
    Jul 11, 2023

    Hepatocellular Carcinoma Resectable Trial in Fuzhou (neoadjuvant therapy)

    Not yet recruiting
    • Hepatocellular Carcinoma Resectable
    • neoadjuvant therapy
    • Fuzhou, Fujian, China
      The First Affiliated Hospital of Fujian Medical University
    Aug 19, 2023